Hill Drug Pricing Scrutiny Starts With Patients, Researchers

The House Oversight Committee will begin a series of hearings on the drug industry’s pricing practices with testimony from patient advocates and researchers.

The committee has yet to announce the specifics of who will testify at this first hearing, set for Jan. 29, and multiple experts in the field and patient advocacy groups say they have yet to be contacted by the committee.

Government watchdogs said the actions Chairman Elijah Cummings (D-Md.) have taken so far in this investigation show he’s serious about conducting a comprehensive investigation, not one driven by scandal.

“The Committee will hold its first of several ...